Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 23Fallopian Tube Neoplasms 20Breast Neoplasms 9Carcinoma, Ovarian Epithelial 8Sarcoma 6Neoplasms 4Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Sarcoma, Kaposi 2Sarcoma, Ewing 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Multi-centric Castleman's Disease 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Leiomyosarcoma 2Hodgkin Disease 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Vulvar Neoplasms 1Vaginal Neoplasms 1Vaccinia 1Uterine Cervical Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma 1Recurrence 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1

Interventions

Cyclophosphamide 13Specimen Handling 9cabozantinib 8X-Rays 8Magnetic Resonance Spectroscopy 8fludarabine 7Phantoms, Imaging 7Biopsy 7Temozolomide 6Methotrexate 6Zoledronic Acid 5Gemcitabine 5Doxorubicin 5regorafenib 4pembrolizumab 4Vincristine 4Nuclear Medicine Department, Hospital 4Nivolumab 4Ifosfamide 4Cisplatin 4olaparib 3irinotecan sucrosofate 3fludarabine phosphate 3dinutuximab 3Surveys and Questionnaires 3Irinotecan 3Etoposide 3ulixertinib 2tipifarnib 2tazemetostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × liposomal doxorubicin × 1 year × Clear all
NCT05210374 2026-06-05

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Case Comprehensive Cancer Center

Phase 1 Recruiting
24 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡